Literature DB >> 3107122

Insulin rapidly increases diacylglycerol by activating de novo phosphatidic acid synthesis.

R V Farese, T S Konda, J S Davis, M L Standaert, R J Pollet, D R Cooper.   

Abstract

The mechanisms whereby insulin increases diacylglycerol in BC3H-1 myocytes were examined. When [3H]arachidonate labeling of phospholipids was used as an indicator of phospholipase C activation, transient increases in [3H]diacylglycerol were observed between 0.5 and 10 minutes after the onset of insulin treatment. With [3H]glycerol labeling as an indicator of de novo phospholipid synthesis, [3H]diacylglycerol was increased maximally at 1 minute and remained elevated for 20 minutes. [3H]Glycerol-labeled diacylglycerol was largely derived directly from phosphatidic acid. Insulin increased de novo phosphatidic acid synthesis within 5 to 10 seconds; within 1 minute, this synthesis was 60 times greater than that of controls. Thus, the initial increase in diacylglycerol is due to both increased hydrolysis of phospholipids and a burst of de novo phosphatidic acid synthesis. After 5 to 10 minutes, de novo phosphatidic acid synthesis continues as a major source of diacylglycerol. Both phospholipid effects of insulin seem important for generating diacylglycerol and other phospholipid-derived intracellular signaling substances.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3107122     DOI: 10.1126/science.3107122

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  33 in total

1.  Platelet-derived growth factor stimulates synthesis of 1,2-diacylglycerol from monoacylglycerol in Balb/c 3T3 cells.

Authors:  Y Hata; E Ogata; I Kojima
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

2.  High glucose protects embryonic cardiac cells against simulated ischemia.

Authors:  Vassiliki Malliopoulou; Christodoulos Xinaris; Iordanis Mourouzis; Alexandros D Cokkinos; Nikolaos Katsilambros; Constantinos Pantos; Elissavet Kardami; Dennis V Cokkinos
Journal:  Mol Cell Biochem       Date:  2006-03-16       Impact factor: 3.396

3.  Insulin, oxytocin, and vasopressin stimulate protein kinase C activity in adipocyte plasma membranes.

Authors:  J J Egan; J Saltis; S A Wek; I A Simpson; C Londos
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Identification of two cytosolic diacylglycerol kinase isoforms in rat brain, and in NIH-3T3 and ras-transformed fibroblasts.

Authors:  V M Stathopoulos; A Coco-Maroney; C W Wei; M Goth; C Zaricznyj; I G Macara
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

Review 5.  Regulation of p53 by protein kinase C during multi-stage carcinogenesis.

Authors:  L Magnelli; V Chiarugi
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 6.  Role of kinases in insulin stimulation of glucose transport.

Authors:  A Klip; A G Douen
Journal:  J Membr Biol       Date:  1989-10       Impact factor: 1.843

7.  Possible involvement of normal p21 H-ras in the insulin/insulinlike growth factor 1 signal transduction pathway.

Authors:  B M Burgering; A J Snijders; J A Maassen; A J van der Eb; J L Bos
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

8.  Alteration in 1,2-diacylglycerol level and its fatty acid composition in hearts during the growth of hamsters.

Authors:  K Okumura; Y Yamada; J Kondo; H Hashimoto; T Ito; K Ogawa
Journal:  Basic Res Cardiol       Date:  1990 Mar-Apr       Impact factor: 17.165

9.  Sphingosine, an inhibitor of protein kinase C, suppresses the insulin-like effects of growth hormone in rat adipocytes.

Authors:  J Smal; P De Meyts
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

10.  Norepinephrine-induced 1,2-diacylglycerol accumulation and change in its fatty acid composition in the isolated perfused rat heart.

Authors:  K Okumura; Y Shirai; J Kondo; H Hashimoto; T Ito; K Ogawa
Journal:  Mol Cell Biochem       Date:  1990-03-27       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.